SAMANTHA ZARRO: Open Payments
NPI 1477179984 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,026 in 47 payments from 10 companies in 2025. Trend: 2023 $866 · 2024 $2,233 · 2025 $2,026
Food & beverage: $1,927Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $695 |
| Janssen Biotech, Inc. | 11 | $433 |
| Boston Scientific Corporation | 2 | $270 |
| Mirum Pharmaceuticals, Inc. | 3 | $185 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $162 |
| Ferring Pharmaceuticals Inc. | 3 | $101 |
| Madrigal Pharmaceuticals | 2 | $66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| PFIZER INC. | 1 | $27 |
Products named: TREMFYA, SKYRIZI, RINVOQ, Livmarli, Resolution 360 Clip, General - Hemostasis, MAVYRET, REBYOTA.
Industry payments across TX — which companies pay providers there.
